But in October 2019 the cancer returned, and scans showed it had spread to her lung, lymph nodes and chest bone and she was told she had a poor prognosis. 'Horrible side effects'
Two months later, the mother-of-two was offered a two-year trial at The Christie of an experimental medicine combined with Atezolizumab, an immunotherapy drug. Doctors have told her she is now showing no evidence of the disease.